Cancer research may yield a potential COVID-19 therapeutic. Dr. Bob interviews Dr. John Rothman of Tyme Technologies about the promising preclinical studies for a new therapeutic. Plus, Kate speaks with Michelle Whitlock, a two-time cervical cancer survivor who had a heart attack in her 40s. She shares the importance of self-advocacy in the doctor’s office.
John Rothman, Ph.D.
Executive VP of Product Development, Tyme Technologies Inc.
Dr. Rothman has more than 30 years of experience in product development across many disciplines and markets. He was a clinical scientist at the pharmaceutical companies, Schering Plough and Roche, where he was also a clinical director for a number of different therapeutic areas and senior director for all of Roche’s data acquisition, statistical analysis and report writing for all experimental and approved drugs in the Roche portfolio. His work on Interferon-α in AIDs-related Kaposi’s Sarcoma resulted in the approval of the first recombinant drug and AIDS treatment called Referon-A.
Dr. Rothman later held R&D director positions at Roche and was associated with a number of development programs that resulted in marketed drugs, including Rocephin, Coactin, Rimadyl, Larotid, Dalmane, Rimantidine, Gantrisin, Versed, and more. Dr. Rothman was later an executive vice president of science and operations at the biotech company, Advaxis, where he was responsible for R&D, toxicology, regulatory, chemistry, data management, manufacturing, and intellectual property. Dr. Rothman has since held chief executive roles with several biopharmaceutical companies. During his career, Dr. Rothman filed numerous patents and managed a portfolio of over 80 issued patents and patent applications.
Terry Wilcox, Executive Director, Patients Rising
Dr. Robert Goldberg, “Dr. Bob”, Co-Founder and Vice President of the Center for Medicine in the Public Interest.
Kate Pecora, Field Correspondent
Dr. John Rothman
Tyme’s Oncology Research Reveals Potential New Oral Therapy TYME-19 in the Fight Against COVID-19
In ‘Power Grab,’ Health Secretary Azar Asserts Authority Over F.D.A.
Patients Rising Concierge
The successful patient is one who can get what they need when they need it. We all know insurance slows us down, so why not take matters into your own hands. Our Navigator is an online tool that allows you to search a massive network of health-related resources using your zip code so you get local results. Get proactive and become a more successful patient right now at PatientsRisingConcierge.org
Have a question or comment about the show, want to suggest a show topic or share your story as a patient correspondent?
Drop us a line: email@example.com
The views and opinions expressed herein are those of the guest(s)/ author(s) and do not reflect the official policy or position of Patients Rising.